Organogenesis Holdings Inc. Class A Common Stock (ORGO)

About ORGO

Organogenesis Holdings Inc., a regenerative medicine company, develops, manufactures, and commercializes products for the advanced wound care, and surgical and sports medicine markets in the United States. Its advanced wound care products include Affinity and Novachor, which are amnion and chorion placental allografts for use in the care of chronic and acute wounds as protective barriers and extracellular matrix (ECM…

Sector

Health Care

Industry

Biotechnology: Pharmaceutical Preparations

Employees

854

Website

investors.organogenesis.com

Fundamentals

1-day range

$1.7$1.75

Market cap

$301.10M

P/E (trailing)

84.95

P/E (forward)

-5.61

EPS (trailing)

$-0.02

Dividend yield

—

Beta

1.26

Avg. volume

815.6K

Forecasts

1 analyst ratings

Organogenesis Holdings Inc. Class A Common Stock Competitors

Chosen by industry and closest market cap.

• ORGO

  Organogenesis Holdings Inc. Class A Common Stock

  $1.74

  ▼ 0.00%
  Market cap $301.10MP/E 84.95
  $1.54$7.08
• IRD

  Opus Genetics Inc. Common Stock

  $3.7

  ▼ 3.90%
  Market cap $300.54MP/E —
  $1.17$5.81
• VNDA

  Vanda Pharmaceuticals Inc. Common Stock

  $5.29

  ▼ 2.76%
  Market cap $314.51MP/E —
  $4.27$9.94
• FULC

  Fulcrum Therapeutics Inc. Common Stock

  $3.85

  ▲ 0.00%
  Market cap $283.06MP/E —
  $2.83$15.74
• ZNTL

  Zentalis Pharmaceuticals Inc. Common Stock

  $3.8

  ▼ 2.06%
  Market cap $331.02MP/E —
  $1.21$6.95
• BCYC

  Bicycle Therapeutics plc American Depositary Shares

  $4.21

  ▼ 2.77%
  Market cap $270.87MP/E —
  $3.75$9.16
• IMRX

  Immuneering Corporation Class A Common Stock

  $4.99

  ▼ 4.22%
  Market cap $269.79MP/E —
  $3.86$10.08

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Organogenesis (ORGO) Q2 2026 Earnings Call Transcript
  Yahoo · 8/13/2026
• Organogenesis Holdings (ORGO) Stock Fair Value Moves Lower After Guidance Cut And Analyst Caution
  Yahoo · 8/10/2026
• Organogenesis Holdings (ORGO) Is Down 21.5% After Slashing 2026 Guidance And Launching Equity Offering – Has The Bull Case Changed?
  Yahoo · 8/8/2026
• What's going on in today's session
  ChartMill · 8/7/2026
• Which stocks are gapping on Friday?
  ChartMill · 8/7/2026
• 12 Health Care Stocks Moving In Friday's Intraday Session
  Benzinga · 8/7/2026
• Top movers in Friday's pre-market session
  ChartMill · 8/7/2026
• Organogenesis Holdings Inc. Q2 2026 Earnings Call Summary
  Yahoo · 8/7/2026

• Michael Joseph Driscoll · March 9, 2026 · Buy

  10.0K @ $2.67
• Arthur S. Leibowitz · March 9, 2026 · Buy

  5.0K @ $2.68
• Robert Cavorsi · March 1, 2026 · Tax Withholding

  700 @ $3.21

Institutional Ownership

March 31, 2026

Total shares held

59.52M

Total value held

$135.27M

Institutional holders

116